Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin

Cell Growth and Differentiation

Volumn 10, Issue 11, 1999, Pages 739-748

  Gilmour, Susan K ^a   Birchler, Mary ^a   Smith, Mary K ^a   Rayca, Kathryn ^a   Mostochuk, Judith ^a  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN E; KI 67 ANTIGEN; ORNITHINE DECARBOXYLASE; PROTEIN BAX; PROTEIN P27; PROTEIN P53; RAS PROTEIN; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; GENE OVEREXPRESSION; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKIN TUMOR; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIVISION; CELL NUCLEUS; CELLS, CULTURED; CYCLIN A; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, RAS; IN SITU NICK-END LABELING; KERATINOCYTES; KI-67 ANTIGEN; MICE; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; ORNITHINE DECARBOXYLASE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN-SERINE-THREONINE KINASES; SKIN; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 0032716227     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. O'Brien, T. G., Simsiman, R. C., and Boutwell, R. K. Induction of the polyamine biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res., 35: 1662-1670, 1975.
2. Gilmour, S., Aglow, E., and O'Brien, T. G. Heterogeneity of omithine decarboxylase expression in 12-O-tetradecanoylphorbol-13-acetate-treated mouse skin and in epidermal tumors. Carcinogenesis (Lond.), 7: 943-947, 1986.
3. Gilmour, S. K., Verma, A. K., Madara, T., and O'Brien, T. G. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis. Cancer Res., 4: 1221-1225, 1987.
4. Koza, R. A., Megosh, L. C., Palmieri, M., and O'Brien, T. G. Constitutively elevated levels of omithine and polyamines in mouse epidermal papillomas. Carcinogenesis (Lond.), 12: 1619-1625, 1991.
5. Bollag, W. Prophylaxis of chemically induced benign and malignant epithelial tumors by vitamin A acid (retinoic acid). Eur. J. Cancer, 8: 689-693, 1972.
6. Verma, A. K., Ashendel, C. L., and Boutwell, R. K. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal omithine decarboxylase activity, the accumulation of prostaglandins and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res., 40: 308-315, 1980.
7. Takigawa, M., Verma, A. K., Simsiman, R. C., and Boutwell, R. K. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by α-difluoromethylornithine. Cancer Res., 43: 3732-3738, 1983.
8. Weeks, C. E., Hermann, A. L., Nelson, F. R., and Slaga, T. S. α-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and Carcinogenesis in mouse skin. Proc. Natl. Acad. Sci. USA, 79: 6028-6032, 1982.
9. Clifford, A., Morgan, D., Yuspa, S. H., Peralta Soler, A., and Gilmour, S. Role of ornithine decarboxylase in epidermal tumorigenesis. Career Res., 55: 1680-1686, 1995.
10. Smith, M. K., Trempus, C. S., and Gilmour, S. K. Cooperation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin. Carcinogenesis (Lond.), 19: 1409-1415, 1998.
11. Pegg, A. E., Recent advances in the biochemistry of polyamines in eukaryotes. Biochem. J., 234: 249-262, 1986.
12. Tabor, C. W., and Tabor, H. Polyamines. Annu. Rev. Biochem., 53: 749-790, 1984.
13. 1. J. Cell Physiol., 94: 161-170, 1978.
14. Kramer, D. L. Fogel-Petrovic, M., Miller, J., Diegelman, P., McManis, J. S., Bergeron, R. J., and Porter, C. W. Effects of novel spermine analogs on cell cycle progression and apoptosis in MALME-3M human melanoma cells. Cancer Res., 57: 5521-5527, 1997.
15. Laitinen, J., Stenius, K., Eloranta, T. O., and Höltta, E. Polyamines may regulate S-phase progression but not the dynamic changes of chromatin during the cell cycle. J. Cell. Biochem., 68: 200-212, 1998.
16. Gallo, C. J., Koza, R. A., and Herbst, E. J. Polyamines and HeLa cell DNA replication. Biochem. J., 238: 37-42, 1986.
17. Pojhanpelto, P., Nordling, S., and Knuutila, S. Flow cylometric analysis of the cell cycle in polyamine depleted-cells. Cytometry, 16: 331-338, 1994.
18. Fredlund, J. O., and Oredsson, S. M. Impairment of DNA replication within one cell cycle after seeding of cells in the presence of a polyamine-biosynthesis inhibitor. Eur. J. Biochem., 237: 539-544, 1996.
19. Fuller, J. M., Gerner, E. W., and Russell, D. H. Polyamine biosynthesis and accumulation during the G1 to S Phase transition. J. Cell. Physiol., 93: 81-87, 1977.
20. Kaczmarek, L., Calabretta, B., Ferrari, S., and Riel, J. K. Cell cycle dependent expression of human omithine decarboxylase. J. Cell. Physiol., 132: 545-551, 1987.
21. Bello-Fernandez, C., Packham, G., and Cleveland, J. L. The ornithine decarboxylase gene is a transcriptional target of c-myc. Proc. Natl. Acad. Sci. USA, 90: 7804-7808, 1993.
22. Wagner, A. J., Meyers, C., Laimins, L. A., and Hay, N. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ., 4: 879-883, 1993.
23. Pena, A., Reddy, C. D., Wu, S., Hickok, N., Reddy, E. P., Yumet, G., Soprano, D. R., and Soprano, K. J. Regulation of human ornithine decarboxylase expression by the c-Myc/Max protein complex. J. Biol. Chem., 268: 27277-27285, 1993.
24. Packham, G., and Cleveland, J. L. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways. Oncogene, 15: 1219-1232, 1997.
25. 1-phase progression. Genes Dev., 13: 1501-1512, 1999.
26. Schluter, C., Duchrow, M., and Wohlenberg, C. The cell proliferation-associated antigen of antibody Ki67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J. Cell Biol., 123: 513-522, 1993.
27. Bravo, R. Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp. Cell Res., 163: 287-293, 1986.
28. Buick, R. N., and Pollak, M. N. Perspectives on clonogenic tumor cells, stem cells, and oncogenes. Cancer Res., 44: 4909-4918, 1984.
29. Shore, L. J., Peralta Soler, A., and Gilmour, S. K. Omithine decarboxylase expression leads to translocation and activation of protein kinase CK2 in vivo. J. Biol. Chem., 272: 12536-12543, 1997.
30. 1-to-S phase transition. Mol. Cell. Biol., 175: 2612-2624, 1995.
31. Albrecht, J. H., and Hansen, L. K., Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. Cell Growth Differ., 10: 397-404, 1999.
32. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
33. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
34. Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L-H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., Swindell, E., Fox, M. P., and Wei, N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 6: 387-400, 1995.
35. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
36. WAF1 complexes during the cell cycle. Proc. Natl. Acad. Sci. USA, 95: 12254-12259, 1998.
37. Filmus, J., Robles, A. I., Shi, W., Wong, M. J., Colombo, L. L., and Conti, C. J. Induction of cyclin D1 overexpression by activated ras. Oncogene, 9: 3627-3633, 1994.
38. Robles, A. I., Rodriguez-Puebla, M. L., Glick, A. B., Trempus, C., Hansen, L., Sicinski, P., Tennant, R. W., Weinberg, R. A., Yuspa, S. H., and Conti, C. J. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev., 12: 2469-2474, 1998.
39. Leone, G., DeGregori, J., Sears, R., Jakol, L., and Nevins, J. R. Myc, and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature (Lond.), 387: 422-426, 1997.
40. 1 cyclin-cdk complexes. EMBO J., 14: 4814-4826, 1995.
41. Galaktionov, K., Chen, X., and Beach, D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature (Lond.), 382: 511-517, 1996.
42. LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., and Harlow, E. New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11: 847-862, 1997.
43. WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells. Cancer Res., 58: 5053-5056, 1998.
44. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, E., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fomace, J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell, 71: 587-597, 1992.
45. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
46. Woodworth, C. D., Wang, H., Simpson, S., Alvarez-Salas, L. M., and Notario, V. Overexpression of wild-type p53 alters growth and differentiation of normal human keratinocytes but not human papillomavirus-expressing cell lines. Cell Growth Differ., 4: 367-376, 1993.
47. Weinberg, W. C., Azzoli, C. G., Chapman, K. Levine, A. J., and Yuspa, S. H. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. Oncogene, 10: 2271-2279, 1995.
48. Hall, P. A., McKee, P. H., Menage, H., Dover, R., and Lane, D. P. High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8: 203-207, 1993.
49. Berg, R. J. W., van Kranen, H. J., Rebel, H. G., De Vries, A., Van Vloten, W. A., Van Kreul, C. F., Van Der Leun, J. C., and De Gruijl, F. R. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc. Natl. Acad. Sci. USA, 93: 274-278, 1996.
50. Li, G., Mitchell, D. L., Ho, V. D., Reed, J. C., and Tron, V. A. Decreased DNA repair but normal apoptosis in ultraviolet-irradiated skin of p53-transgenic mice. Am. J. Pathol., 148: 1113-1123, 1996.
51. Foord, O., Navot, N., and Rotter, V. Isolation and characterization of DNA sequences that are specifically bound by wild-type p53. Mol. Cell. Biol., 13: 1378-1384, 1993.
52. Barak, Y., Juven, T., Haffner, R., and Oren, M. mdm2 expression is induced by wild type p53 activity. EMBO J., 12: 461-468, 1993.
53. Ha, H. C., Woster, P. M., Yager, J. D., and Casero, R. A., Jr. The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc. Natl. Acad. Sci. USA, 94: 11557-11562, 1997.
54. Packham, G., and Cleveland, J. L. Ornithine decarboxylase is a mediator of c-myc-induced apoptosis. Mol. Cell. Biol., 14: 5741-5747, 1994.
55. Tome, M. E., Fiser, S. M., and Gerner, E. W. Consequences of aberrant ornithine decarboxylase regulation in rat hepatoma cells. J. Cell Physiol., 158: 237-244, 1994.
56. Tobias, K. E., and Kahana, C. Exposure to ornithine results in excessive accumulation of putrescine and apoptotic cell death in ornithine decarboxylase overproducing mouse myeloma cells. Cell Growth Differ., 6: 1279-1285, 1995.
57. Poulin, R., Pelletier, G., and Pegg, A. E. Induction of apoptosis by excessive polyamine accumulation in ornithine decarboxylase-overproducing L1210 cells. Biochem. J., 311: 723-727, 1995.
58. Katayose, Y., Kim, M., Rakkar, A. N. S., Li, Z., Cowan, K. H., and Seth, P. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res., 57: 5441-5445, 1997.
59. +, integrin levels during keratinocyte terminal differentiation. J. Cell Biol., 128: 1209-1219, 1995.
60. Haake, A. R., Roublevskaia, I., and Cooklls, M. Apoptosis: a role In skin aging? J. Investig. Dermatol. Symp. Proc., 3: 28-35, 1998.
61. Pandey, S., and Wang, E. Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J. Cell Biochem., 58: 135-150, 1995.
62. Wang, E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bc12 is involved. Cancer Res., 55: 2284-2292, 1995.
63. Danno, K., and Horio, T. Formation of UV-induced apoptosis relates to the cell cycle. Br. J. Dermatol., 107: 423-428, 1982.
64. Nigro, J. M., Aldape, K. D., Hess, S. M., and Tlsty, T. D. Cellular adhesion regulates p53 protein levels in primary human keratinocytes. Cancer Res., 57: 3635-3639, 1997.
65. Shin, T. H., Paterson, A. J., Kudlov, J. E. p53 stimulates transcription from the human transforming growth factor α promoter a potential growth-stimulatory role for p53. Mol. Cell. Biol., 15: 4694-4701, 1995.
66. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., LeVillain, J. P., Troalen, F., Trouche, D., and Harel-Bellan, A. Retino-blastoma protein represses transcription by recruiting a histone deacetylase. Nature (Lond.), 391: 601-605, 1998.
67. Perkins, N. D., Felzien, L. K., Leung, K., Beach, D. H., and Nabel, G. J. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science (Washington DC), 275; 523-527, 1997.
68. Megosh, L., Gilmour, S. K., Rosson, D., Peralta Soler, A., Blessing, M., Sawicki, J. A., and O'Brien, T. G. Increased frequency of spontaneous skin tumors In transgenic mice which overexpress omithine decarboxylase. Cancer Res., 55: 4205-4209, 1995.
69. Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shlbuya, M., Sherr, C. J., and Kato, J. Y. D-type cyclin-dependent klnase activity in mammalian cells. Mol. Cell. Blol., 14: 2066-2076, 1994.
70. Yuspa, S. H., and Harris, C. C. Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp. Cell Res., 86: 95-105, 1974.
71. Hennings, H., Michael, D., Cheng, C., Steinert, P., Holbrook, K., and Yuspa, S. H. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell, 19: 245-254, 1980.
72. Morris, R. J., and Potten, C. S. Slowly cycling (label-retaining) epidermal cells behave like clonogenic stem cells in vitro. Cell Prolif., 27: 279-289, 1994.